Evidence map›Paper›PMID 40002894›Full record

ArticleBiomedicines2025

SNX19 Interacts with Caveolin-1 and Flotillin-1 to Regulate D

Bibhas Amatya, Jacob Q M Polzin, Van A M Villar, Jiang Yang, Prasad Konkalmatt, Xiaoyan Wang, Raisha C Cadme, Peng Xu, John J Gildea, Santiago Cuevas and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Bibhas AmatyaDivision of Kidney Diseases & Hypertension, Department of Medicine, The George Washington University School of Medicine & Health Sciences, Washington, DC 20052, USA.
Jacob Q M PolzinDivision of Kidney Diseases & Hypertension, Department of Medicine, The George Washington University School of Medicine & Health Sciences, Washington, DC 20052, USA.ORCID 0009-0000-8202-0432
Van A M VillarDivision of Kidney Diseases & Hypertension, Department of Medicine, The George Washington University School of Medicine & Health Sciences, Washington, DC 20052, USA.
Jiang YangDivision of Nephrology, Department of Medicine, University of Maryland School of Medicine, 20 Penn Street, HSF II, Baltimore, MD 21201, USA.
Prasad KonkalmattDivision of Kidney Diseases & Hypertension, Department of Medicine, The George Washington University School of Medicine & Health Sciences, Washington, DC 20052, USA.
Xiaoyan WangDivision of Kidney Diseases & Hypertension, Department of Medicine, The George Washington University School of Medicine & Health Sciences, Washington, DC 20052, USA.ORCID 0000-0001-7406-5008
Raisha C CadmeDivision of Kidney Diseases & Hypertension, Department of Medicine, The George Washington University School of Medicine & Health Sciences, Washington, DC 20052, USA.
Peng XuDepartment of Pathology, University of Virginia Health Sciences Center, Charlottesville, VA 22908, USA.ORCID 0000-0002-2673-7161
John J GildeaDepartment of Pathology, University of Virginia Health Sciences Center, Charlottesville, VA 22908, USA.
Santiago CuevasDivision of Kidney Diseases & Hypertension, Department of Medicine, The George Washington University School of Medicine & Health Sciences, Washington, DC 20052, USA.ORCID 0000-0002-0832-5446
Ines ArmandoDivision of Kidney Diseases & Hypertension, Department of Medicine, The George Washington University School of Medicine & Health Sciences, Washington, DC 20052, USA.
Robin A FelderDepartment of Pathology, University of Virginia Health Sciences Center, Charlottesville, VA 22908, USA.ORCID 0000-0003-2797-4289
Pedro A JoseDivision of Kidney Diseases & Hypertension, Department of Medicine, The George Washington University School of Medicine & Health Sciences, Washington, DC 20052, USA.
Hewang LeeDivision of Kidney Diseases & Hypertension, Department of Medicine, The George Washington University School of Medicine & Health Sciences, Washington, DC 20052, USA.ORCID 0000-0003-1338-2573

Funding

Spatiotemporal transregulation of D1-like angiotensin receptors in genetically...P01HL074940 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI JOSE, PEDRO A. · 2004 to 2020
$31.8M
RENAL DOPAMINE-1 RECEPTOR DEFECT IN HYPERTENSIONR01DK039308 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI JOSE, PEDRO A. · 1987 to 2020
$7.4M
D2 receptor variation and renal dysfunctionR01DK134574 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI Pedro A. Jose · 2023 to 2026
$2.8M
Lipid rafts, dopamine 1 receptor, and hypertensionR01DK119652 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI JOSE, PEDRO A. · 2020 to 2023
$2.6M
Renal G Protein-Coupled Receptor 37L1 Regulates Blood PressureR56DK116828 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI KONKALMATT, PRASAD · 2018 to 2018
$100k
NHLBI NIH HHS P01 HL074940NIDDK NIH HHS R01 DK039308NIDDK NIH HHS R01 DK119652NIDDK NIH HHS R01 DK134574NIDDK NIH HHS R56 DK116828NIH HHS P01HL074940NIH HHS R01DK039308NIH HHS R01DK119652NIH HHS R01DK134574
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

caveolin-1dopamine D1 receptorendocytosisflotillin-1lipid raftSNX19

Identifiers

PMID40002894
PMCPMC11853350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.